The following is a summary of “Factors predicting local or systemic side effects related to intravesical BCG (Bacillus Calmette-Guérin) therapy: a retrospective observational study,” published in the March 2025 issue of BMC Urology by Aksakalli et al. Intravesical Bacillus Calmette-Guérin (BCG) is a common adjuvant treatment for non-muscle invasive bladder tumors. However, systemic and local […]
The post Predictors of Side Effects in Intravesical BCG Therapy for Bladder Cancer first appeared on Physician’s Weekly.
